A10356 Summary:

BILL NOA10356
 
SAME ASSAME AS S07839
 
SPONSORBrennan
 
COSPNSRColton, Cymbrowitz, Dinowitz, Galef, Gunther, Lupardo, Miller, Stirpe, Duprey, McDonough, Montesano, Wozniak, Crespo, Jaffee, Otis, Seawright, Joyner, Crouch, Mosley
 
MLTSPNSRHyndman, Magee, Schimel, Simon
 
Amd 3333, Pub Health L
 
Requires prescription bottles containing opioids to have a label affixed concerning the addictive nature of the drug.
Go to top    

A10356 Actions:

BILL NOA10356
 
05/23/2016referred to health
Go to top

A10356 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A10356
 
SPONSOR: Brennan (MS)
  TITLE OF BILL: An act to amend the public health law, in relation to labeling prescription bottles of opioids   PURPOSE: This bill will require manufacturers and software companies that prepare labels for prescription drugs, which are approved by the state, to contain a warning regarding the addictive properties of opioid drugs.   SUMMARY OF PROVISIONS: Section 1 - amends subdivision 2 of section 3333 of the Public Health Law to add a new paragraph (d) providing that a new warning must be added to labels of opioid drugs -- "Warning. This drug is highly addic- tive. Please consult your pharmacist or physician before using." Section 2 - provides that this act shall take effect ninety days after it shall have become law, and provides that any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.   JUSTIFICATION: The social and personal cost of opioid addiction is a critical issue for New York State, and indeed for the entire country. This bill simply provides a clear warning to patients that have been prescribed opioid drugs that the over-use of these drugs can lead to addiction. Hopefully such warning will help patients to be careful not to utilize these drugs any more than is absolutely necessary.   LEGISLATIVE HISTORY: New bill   FISCAL IMPLICATIONS: None   EFFECTIVE DATE: Immediately
Go to top

A10356 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          10356
 
                   IN ASSEMBLY
 
                                      May 23, 2016
                                       ___________
 
        Introduced  by  M.  of  A. BRENNAN, COLTON, CYMBROWITZ, DINOWITZ, GALEF,
          GUNTHER, LUPARDO, MILLER, STIRPE, DUPREY, McDONOUGH, MONTESANO,  WOZN-
          IAK  --  Multi-Sponsored  by -- M. of A. MAGEE, SCHIMEL, SIMON -- read
          once and referred to the Committee on Health
 
        AN ACT  to  amend  the  public  health  law,  in  relation  to  labeling
          prescription bottles of opioids

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. Subdivision 2 of section 3333 of the public health  law  is
     2  amended by adding a new paragraph (d) to read as follows:
     3    (d)  In  addition to the other requirements of this subdivision, where
     4  the controlled substance being dispensed is an opioid,  there  shall  be
     5  affixed to the container a label upon which is indelibly typed, printed,
     6  or  otherwise  legibly written "Warning.  This drug is highly addictive.
     7  Please consult your pharmacist or physician before using."
     8    § 2. This act shall take effect on the ninetieth day  after  it  shall
     9  have  become  a  law.    Effective  immediately, the addition, amendment
    10  and/or repeal of any rule or regulation necessary for the implementation
    11  of this act on  its  effective  date  are  authorized  to  be  made  and
    12  completed on or before such effective date.
 
 
 
 
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD15387-01-6
Go to top